» Articles » PMID: 30439873

Global Routine Vaccination Coverage - 2017

Overview
Date 2018 Nov 16
PMID 30439873
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Endorsed by the World Health Assembly in 2012, the Global Vaccine Action Plan 2011-2020 (GVAP) (1) calls on all countries to reach ≥90% national coverage with all vaccines in the country's national immunization schedule by 2020. This report updates previous reports (2,3) and presents global, regional, and national vaccination coverage estimates and trends as of 2017. It also describes the number of infants surviving to age 1 year (surviving infants) who did not receive the third dose of diphtheria and tetanus toxoids and pertussis-containing vaccine (DTP3), a key indicator of immunization program performance (4,5), with a focus on the countries with the highest number of children who did not receive DTP3 in 2017. Based on the World Health Organization (WHO) and United Nations Children's Fund (UNICEF) estimates, global DTP3 coverage increased from 79% in 2007 to 84% in 2010, and has remained stable from 2010 to 2017 (84% to 85%). In 2017, among the 19.9 million children who did not receive DTP3 in the first year of life, 62% (12.4 million) lived in 10 countries. From 2007 to 2017, the number of children who had not received DTP3 decreased in five of these 10 countries and remained stable or increased in the other five. Similar to DTP3 coverage, global coverage with the first measles-containing vaccine dose (MCV1) increased from 80% in 2007 to 84% in 2010, and has remained stable from 2010 to 2017 (84% to 85%). Coverage with the third dose of polio vaccine (Pol3) has remained stable at 84%-85% since 2010. From 2007 to 2017, estimated global coverage with the second MCV dose (MCV2) increased from 33% to 67%, as did coverage with the completed series of rotavirus (2% to 28%), pneumococcal conjugate (PCV) (4% to 44%), rubella (26% to 52%), Haemophilus influenzae type b (Hib) (25% to 72%) and hepatitis B (HepB) (birth dose: 24% to 43%; 3-dose series: 63% to 84%) vaccines. Targeted, context-specific strategies are needed to reach and sustain high vaccination coverage, particularly in countries with the highest number of unvaccinated children.

Citing Articles

Delayed completion of pneumococcal conjugate vaccination among children 4-48 months in rural Uganda: a socio-demographic inquiry.

Malemo H, Tamale A, Kakwangire P, Igwe M, Mwine D, Asiimwe I BMC Pediatr. 2025; 25(1):29.

PMID: 39810121 PMC: 11730156. DOI: 10.1186/s12887-025-05388-z.


Individual and community level maternal factors for zero-dose children in Ethiopia using mini-EDHS 2019: a mixed effects model.

Agimas M, Alemayehu M, Tesfie T, Tilahun W, Asferie W, Aweke M BMJ Open. 2025; 15(1):e085235.

PMID: 39773798 PMC: 11749608. DOI: 10.1136/bmjopen-2024-085235.


Geospatial mapping to assess the distribution and determinants of zero dose vaccination status hot spots among children in Ethiopia using EDHS 2019: Spatial and geographical weighted regression.

Agimas M, Asmamaw M, Hailu M, Kidie T, Abuhay H, Yismaw G PLoS One. 2024; 19(12):e0312610.

PMID: 39739825 PMC: 11687766. DOI: 10.1371/journal.pone.0312610.


Prevalence and Factors Associated with Zero-Dose Children amongst Nomadic and Non-Nomadic Fulani in Yobe State, North-East Nigeria.

Ibrahim U, Abdulhamid D, Kofi B, Wade M, Danzomo A, Audu S Niger Med J. 2024; 65(5):775-791.

PMID: 39633685 PMC: 11612329. DOI: 10.60787/nmj-v65i3.545.


Timely Vaccination and Its Associated Factors Among Parents With Children Aged From 0 to 23 Months in Wolaita Zone Public Hospitals, Southern Ethiopia, 2024: A Facility-Based Cross-Sectional Study.

Geta Hardido T, Atinafu Ataro B, Elifios E Glob Pediatr Health. 2024; 11:2333794X241297034.

PMID: 39610854 PMC: 11603463. DOI: 10.1177/2333794X241297034.


References
1.
Burton A, Monasch R, Lautenbach B, Gacic-Dobo M, Neill M, Karimov R . WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ. 2009; 87(7):535-41. PMC: 2704038. DOI: 10.2471/blt.08.053819. View

2.
Okwo-Bele J, Cherian T . The expanded programme on immunization: a lasting legacy of smallpox eradication. Vaccine. 2012; 29 Suppl 4:D74-9. DOI: 10.1016/j.vaccine.2012.01.080. View

3.
Wallace A, Ryman T, Dietz V . Overview of global, regional, and national routine vaccination coverage trends and growth patterns from 1980 to 2009: implications for vaccine-preventable disease eradication and elimination initiatives. J Infect Dis. 2014; 210 Suppl 1:S514-22. PMC: 4663673. DOI: 10.1093/infdis/jiu108. View

4.
Casey R, Dumolard L, Danovaro-Holliday M, Gacic-Dobo M, Diallo M, Hampton L . Global Routine Vaccination Coverage, 2015. MMWR Morb Mortal Wkly Rep. 2016; 65(45):1270-1273. DOI: 10.15585/mmwr.mm6545a5. View

5.
Feldstein L, Mariat S, Gacic-Dobo M, Diallo M, Conklin L, Wallace A . Global Routine Vaccination Coverage, 2016. MMWR Morb Mortal Wkly Rep. 2017; 66(45):1252-1255. PMC: 5726243. DOI: 10.15585/mmwr.mm6645a3. View